• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多非利特阻断肿瘤相关 Kv10.1 通道:与胺碘酮的比较。

Dronedarone blockage of the tumor-related Kv10.1 channel: a comparison with amiodarone.

机构信息

School of Medicine. Department of Physiology, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.

School of Medicine. Department of Biochemistry, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.

出版信息

Pflugers Arch. 2020 Jan;472(1):75-87. doi: 10.1007/s00424-019-02342-8. Epub 2020 Jan 2.

DOI:10.1007/s00424-019-02342-8
PMID:31897736
Abstract

Kv10.1 (Eag1, or KCNH1) is a human potassium-selective channel associated with tumor development. In this work, we study the interaction of the drug dronedarone with Kv10.1. Dronedarone presents two chemical modifications aimed to lessen side effects produced by its parent molecule, the antiarrhythmic amiodarone. Hence, our observations are discussed within the framework of a previously reported interaction of amiodarone with Kv10.1. Additionally, we show new data regarding the interaction of amiodarone with the channels. We found that, unexpectedly, the effect of dronedarone on Kv10.1 differs both quantitatively and qualitatively to that of amiodarone. Among other observations, we found that dronedarone seems to be an open-pore blocker, in contrast to the reported behavior of amiodarone, which seems to inhibit from both open and closed states. Additionally, herein we provide evidence showing that, in spite of their chemical similarity, these molecules inhibit the K conductance by binding to non-overlapping, independent (non-allosterically related) sites. Also, we show that, while amiodarone inhibits the Cole-Moore shift, dronedarone is unable to inhibit this voltage-dependent characteristic of Kv10.1.

摘要

Kv10.1(Eag1,或 KCNH1)是一种与肿瘤发生相关的人类钾选择性通道。在这项工作中,我们研究了药物决奈达隆与 Kv10.1 的相互作用。决奈达隆有两个化学修饰,旨在减轻其母体分子抗心律失常胺碘酮产生的副作用。因此,我们的观察结果是在先前报道的胺碘酮与 Kv10.1 的相互作用框架内进行讨论的。此外,我们还展示了有关胺碘酮与通道相互作用的新数据。我们发现,出乎意料的是,决奈达隆对 Kv10.1 的作用在数量和质量上都与胺碘酮不同。在其他观察结果中,我们发现决奈达隆似乎是一种开放通道阻滞剂,与报道的胺碘酮行为相反,胺碘酮似乎从开放和关闭状态都抑制。此外,本文提供的证据表明,尽管它们具有化学相似性,但这些分子通过结合非重叠的、独立的(非变构相关的)位点来抑制 K 电导。此外,我们还表明,虽然胺碘酮抑制 Cole-Moore 位移,但决奈达隆不能抑制 Kv10.1 的这种电压依赖性特征。

相似文献

1
Dronedarone blockage of the tumor-related Kv10.1 channel: a comparison with amiodarone.多非利特阻断肿瘤相关 Kv10.1 通道:与胺碘酮的比较。
Pflugers Arch. 2020 Jan;472(1):75-87. doi: 10.1007/s00424-019-02342-8. Epub 2020 Jan 2.
2
Inhibition of the K conductance and Cole-Moore shift of the oncogenic Kv10.1 channel by amiodarone.胺碘酮抑制致癌性 Kv10.1 通道的 K+电导和 Cole-Moore 移位。
Pflugers Arch. 2018 Mar;470(3):491-503. doi: 10.1007/s00424-017-2092-x. Epub 2017 Dec 7.
3
State-independent inhibition of the oncogenic Kv10.1 channel by desethylamiodarone, a comparison with amiodarone.去乙基胺碘酮对致癌性 Kv10.1 通道的无状态抑制作用:与胺碘酮的比较。
Pflugers Arch. 2024 Mar;476(3):323-335. doi: 10.1007/s00424-023-02893-x. Epub 2023 Dec 8.
4
Molecular Dynamics-Derived Pharmacophore Model Explaining the Nonselective Aspect of K10.1 Pore Blockers.基于分子动力学的配体药效团模型解释 K10.1 孔阻滞剂的非选择性。
Int J Mol Sci. 2021 Aug 20;22(16):8999. doi: 10.3390/ijms22168999.
5
Gating Modulation of the Tumor-Related Kv10.1 Channel by Mibefradil.米贝地尔对肿瘤相关钾通道Kv10.1的门控调节作用
J Cell Physiol. 2017 Aug;232(8):2019-2032. doi: 10.1002/jcp.25448. Epub 2017 Jan 11.
6
Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channels.决奈达隆对心脏延迟整流钾电流的两个组成部分HERG和KvLQT1/minK钾通道的急性作用。
Br J Pharmacol. 2003 Nov;140(5):996-1002. doi: 10.1038/sj.bjp.0705502. Epub 2003 Sep 29.
7
Thallium-sensitive fluorescent assay reveals loperamide as a new inhibitor of the potassium channel Kv10.1.铊敏感荧光分析法揭示洛哌丁胺是钾通道 Kv10.1 的一种新抑制剂。
Pharmacol Rep. 2021 Dec;73(6):1744-1753. doi: 10.1007/s43440-021-00304-5. Epub 2021 Jul 2.
8
Chloroquine inhibits tumor-related Kv10.1 channel and decreases migration of MDA-MB-231 breast cancer cells in vitro.氯喹抑制肿瘤相关 Kv10.1 通道,并减少 MDA-MB-231 乳腺癌细胞的体外迁移。
Eur J Pharmacol. 2019 Jul 15;855:262-266. doi: 10.1016/j.ejphar.2019.05.017. Epub 2019 May 10.
9
Procyanidin B1, a novel and specific inhibitor of Kv10.1 channel, suppresses the evolution of hepatoma.原花青素 B1 是一种新型、特异的 Kv10.1 通道抑制剂,可抑制肝癌的演进。
Biochem Pharmacol. 2020 Aug;178:114089. doi: 10.1016/j.bcp.2020.114089. Epub 2020 Jun 10.
10
Mibefradil inhibition of the Cole-Moore shift and K-conductance of the tumor-related Kv10.1 channel.米贝拉地尔对肿瘤相关Kv10.1通道的科尔-穆尔移位和钾电导的抑制作用。
Channels (Austin). 2017 Sep 3;11(5):373-376. doi: 10.1080/19336950.2017.1340072. Epub 2017 Jun 26.

引用本文的文献

1
State-independent inhibition of the oncogenic Kv10.1 channel by desethylamiodarone, a comparison with amiodarone.去乙基胺碘酮对致癌性 Kv10.1 通道的无状态抑制作用:与胺碘酮的比较。
Pflugers Arch. 2024 Mar;476(3):323-335. doi: 10.1007/s00424-023-02893-x. Epub 2023 Dec 8.
2
Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges.靶向离子通道用于癌症治疗:当前进展与未来挑战
Rev Physiol Biochem Pharmacol. 2022;183:1-43. doi: 10.1007/112_2020_46.

本文引用的文献

1
New Structures and Gating of Voltage-Dependent Potassium (Kv) Channels and Their Relatives: A Multi-Domain and Dynamic Question.新型电压门控钾(Kv)通道及其相关通道的结构和门控:一个多域和动态问题。
Int J Mol Sci. 2019 Jan 10;20(2):248. doi: 10.3390/ijms20020248.
2
Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer.评估 III 类抗心律失常药物作为卵巢癌中新型 MYC 靶向药物。
Gynecol Oncol. 2018 Dec;151(3):525-532. doi: 10.1016/j.ygyno.2018.09.019. Epub 2018 Oct 6.
3
Correction to: Inhibition of the K conductance and Cole-Moore shift of the oncogenic Kv10.1 channel by amiodarone.
对《胺碘酮对致癌性Kv10.1通道的K电导抑制及科尔-穆尔移位》一文的修正
Pflugers Arch. 2018 Jun;470(6):981-993. doi: 10.1007/s00424-018-2131-2.
4
Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.利用一种新颖的计算药物重定位方法(DrugPredict),快速鉴定出用于癌症治疗的有效药物候选物。
Oncogene. 2018 Jan 18;37(3):403-414. doi: 10.1038/onc.2017.328. Epub 2017 Oct 2.
5
Mibefradil inhibition of the Cole-Moore shift and K-conductance of the tumor-related Kv10.1 channel.米贝拉地尔对肿瘤相关Kv10.1通道的科尔-穆尔移位和钾电导的抑制作用。
Channels (Austin). 2017 Sep 3;11(5):373-376. doi: 10.1080/19336950.2017.1340072. Epub 2017 Jun 26.
6
A new mechanism of voltage-dependent gating exposed by K10.1 channels interrupted between voltage sensor and pore.K10.1通道在电压感受器和孔之间中断后揭示的一种电压依赖性门控新机制。
J Gen Physiol. 2017 May 1;149(5):577-593. doi: 10.1085/jgp.201611742. Epub 2017 Mar 30.
7
Structure of the voltage-gated K⁺ channel Eag1 reveals an alternative voltage sensing mechanism.电压门控钾离子通道Eag1的结构揭示了一种不同的电压传感机制。
Science. 2016 Aug 12;353(6300):664-9. doi: 10.1126/science.aaf8070.
8
Interactions between amiodarone and the hERG potassium channel pore determined with mutagenesis and in silico docking.通过诱变和计算机对接确定胺碘酮与hERG钾通道孔之间的相互作用。
Biochem Pharmacol. 2016 Aug 1;113:24-35. doi: 10.1016/j.bcp.2016.05.013. Epub 2016 May 30.
9
Gating Modulation of the Tumor-Related Kv10.1 Channel by Mibefradil.米贝地尔对肿瘤相关钾通道Kv10.1的门控调节作用
J Cell Physiol. 2017 Aug;232(8):2019-2032. doi: 10.1002/jcp.25448. Epub 2017 Jan 11.
10
Kv10.1 K(+) channel: from physiology to cancer.Kv10.1钾离子通道:从生理到癌症
Pflugers Arch. 2016 May;468(5):751-62. doi: 10.1007/s00424-015-1784-3. Epub 2016 Jan 8.